SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia

Published:2021-12-22 Issue:2 Volume:36 Page:562-565
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Mellinghoff Sibylle C.^ORCID,Robrecht Sandra,Mayer Leonie^ORCID,Weskamm Leonie M.^ORCID,Dahlke Christine^ORCID,Gruell Henning^ORCID,Vanshylla Kanika,Schlösser Hans A.,Thelen Martin^ORCID,Fink Anna-Maria^ORCID,Fischer Kirsten,Klein Florian,Addo Marylyn M.^ORCID,Eichhorst Barbara,Hallek Michael,Langerbeins Petra^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-021-01500-1.pdf

Reference11 articles.

1. Chatzikonstantinou T, Kapetanakis A, Scarfò L, Karakatsoulis G, Allsup D, Cabrero AA, et al. COVID-19 severity and mortality in patients with CLL: An update of the international ERIC and Campus CLL study. Leukemia. 2021;35:3444–54.

2. Koch T, Mellinghoff SC, Shamsrizi P, Addo MM, Dahlke C. Correlates of vaccine-induced protection against SARS-CoV-2. Vaccines. 2021;9:238.

3. Braun J, Loyal L, Frentsch M, Wendisch D, Georg P, Kurth F, et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587:270–4.

4. Benjamini O, Rokach L, Itchaki G, Braester A, Shvidel L, Goldschmidt N, et al. Safety and efficacy of BNT162b mRNA Covid19 Vaccine in patients with chronic lymphocytic leukemia. Haematologica. 2021. https://doi.org/10.3324/haematol.2021.279196. Epub ahead of print.

5. Herishanu Y, Avivi I, Aharon A, Shefer G, Levi S, Bronstein Y, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137:3165–73.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens;Frontiers in Oncology;2024-08-26

2. Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia;Annals of Hematology;2024-07-15

3. SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition;npj Vaccines;2024-02-05

4. Hybrid immunity to SARS‐CoV‐2 in patients with chronic lymphocytic leukemia;European Journal of Haematology;2024-02-04

5. Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2;Frontiers in Medicine;2023-07-17